copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Home - Curtana Pharmaceuticals Curtana Pharmaceuticals was founded on a mission to develop the first truly targeted therapies for the treatment of the most aggressive types of brain cancers in adults and children
Management Team - Curtana Pharmaceuticals He has contributed to the progression of over 100 pharmaceutical candidates and 6 marketed products, including the nucleoside analogs Emtricitabine (Truvada) for the treatment of HIV and Adefovir (Hepsera) for treatment of Hepatitis B
Board of Directors - Curtana Pharmaceuticals During his professional career of over 30 years, he has been a clinician and a life sciences executive with experience in the areas of diagnostics, medical devices, pharmaceuticals and biotechnology
CURTANA SIGNS EXCLUSIVE WORLDWIDE LICENSE AGREEMENT WITH UC SAN DIEGO . . . About Curtana Pharmaceuticals na Pharmaceuticals, founded in 2013, is a privately held, preclinical-stage biopharmaceutical company headquartered in San Diego, California The company focuses on the development of novel first-in-cl
Scientific Advisors - Curtana Pharmaceuticals Santosh Kesari, M D , Ph D Director of Neuro-oncology, Professor of Neurosciences, and Chairman of the Department of Translational Neuro-oncology and Neuro-therapeutics, John Wayne Cancer Institute
Technology - Curtana Pharmaceuticals Curtana’s solution is to add an OLIG2 inhibitor to conventional therapy at the time of diagnosis This treatment strategy would not only debulk the tumor, but it would also eliminate the cancer stem cells, thereby markedly delaying or, ideally, preventing the recurrence of the cancer
Contact - Curtana Pharmaceuticals Contact E-mail: info@curtanapharma com Curtana Pharmaceuticals, Inc 10900 Stonelake Blvd , Building 2, Suite 100 Austin, TX 78759 (855) 778-5538
News Releases - Curtana Pharmaceuticals June 15, 2021 - Abstract Published in Neuro-Oncology Demonstrates Curtana Pharmaceuticals’ CT-179 Prolonged Event-free Survival in an Animal Model of Medulloblastoma
Careers - Curtana Pharmaceuticals Curtana Pharmaceuticals is a start-up drug discovery and development company targeting transcription factors, particularly those that are over-expressed in cancer stem cells (CSCs)